Johnson & Johnson and 4 Stocks Traders Are Selling in the Healthcare Sector: JNJ, MRK, ABT, MCK, LUX

Through the early part of trading on Tuesday, October 4, 2011, these stocks are bringing down the Healthcare (NYSE:XLV) sector. Long time Wall St. Cheat Sheet readers know to watch stock prices because Technicals on the Stock Chart are Strong’ is one of the ‘T’s in our CHEAT SHEET investing framework.

Johnson & Johnson (NYSE:JNJ) is one of the sector losers in price. Its shares are trading at $61.19, down 73 cents (-1.4%) from the previous close of $62.08. Johnson & Johnson is a holding company involved in the research and development, manufacture and sale of a range of health care products.

Stock Price Performance: From July 7, 2011, to September 30, 2011, the stock price had fallen $3.63 (-5.4%) from $67.32 to $63.69. The stock price saw one of its best stretches over the last year between June 24, 2011 and July 5, 2011 when shares rose for seven straight trading days, rising 3.9% (+$2.53). It saw one of its worst periods between July 22, 2011 and August 4, 2011 when shares fell for 10 straight trading days, falling 7.3% (-$4.84).

Merck & Co Inc. (NYSE:MRK) is among the price losers in the sector as its stock price is $30.90, down 62 cents (-2.1%) from the previous close of $31.57. Merck is a global research-driven company that develops and manufactures a range of innovative pharmaceutical products to improve human and animal health.

Stock Price Performance: From July 7, 2011, to September 30, 2011, the stock price had fallen $2.61 (-7.4%) from $35.31 to $32.70. The stock price saw one of its best stretches over the last year between April 21, 2011 and May 4, 2011 when shares rose for nine straight trading days, rising 7.4% (+$2.46). It saw one of its worst periods between July 21, 2011 and August 4, 2011 when shares fell for 11 straight trading days, falling 12.9% (-$4.61).

Abbott Laboratories (NYSE:ABT) is among the price losers in the sector. Its shares are trading at $49.32, which is 64 cents (-1.7%) below the previous close of $50.15. Abbott Laboratories is a pharmaceuticals health care company, whose main line of business is in the discovery, development, manufacture, and sale of a broad range of health care products. Its customers include wholesalers, hospitals and commercial laboratories.

Stock Price Performance: From August 4, 2011, to September 30, 2011, the stock price had risen $2.37 (4.9%) from $48.77 to $51.14. The stock price saw one of its best stretches over the last year between March 25, 2011 and April 4, 2011 when shares rose for seven straight trading days, rising 4.6% (+$2.18). It saw one of its worst periods between July 22, 2011 and August 2, 2011 when shares fell for eight straight trading days, falling 5.2% (-$2.75).

McKesson Corporation (NYSE:MCK) stocks are trading at $69.44. This is 60 cents (-1.4%) below the previous close of $70.45, making the company one of the biggest price losers in the sector today. McKesson delivers cost-reducing medicines, pharmaceutical supplies, information, and care management products and services.

Stock Price Performance: From July 7, 2011, to September 30, 2011, the stock price had fallen $11.95 (-14.1%) from $84.65 to $72.70. It saw one of its worst periods between August 11, 2011 and August 22, 2011 when shares fell for eight straight trading days, falling 7.3% (-$5.74). The stock price saw one of its best stretches over the last year between April 18, 2011 and April 27, 2011 when shares rose for seven straight trading days, rising 5.4% (+$4.29).

Shares of Luxottica Group S.p.A. (NYSE:LUX) are trading at $24.40, down 44 cents (-2.7%) from the previous close of $25.07. Luxottica Group designs, manufactures, and distributes fashion, luxury and sport/performance eyewear. It operates in two industry segments: manufacturing and wholesale distribution; and retail distribution.

Stock Price Performance: From July 7, 2011, to September 30, 2011, the stock price had fallen $7.37 (-22.6%) from $32.55 to $25.18. The stock price saw one of its best stretches over the last year between March 25, 2011 and April 6, 2011 when shares rose for nine straight trading days, rising 4.7% (+$1.46). It saw one of its worst periods between March 9, 2011 and March 16, 2011 when shares fell for six straight trading days, falling 9.5% (-$3.02).

 

More from The Cheat Sheet